Peptide Report
AOD-9604 Peptide Report
Catalog report for AOD-9604, generated from Peptide Stacks product data and linked to the matching PeptideReports protocol page when available.
Current Price$59.99 – $104.99 CAD
Common Uses
People commonly discuss AOD-9604 for body-composition and fat-metabolism goals, usually as part of a wider routine that includes nutrition, training, and weight-management habits.
How It Works
AOD-9604 is a modified fragment of the C-terminal region of human growth hormone. It is studied for signaling connected with lipid metabolism without reproducing the full growth-promoting activity profile associated with complete growth hormone.
Storage
Powder form: In lyophilized powder form, AOD-9604 is generally kept sealed, dry, protected from direct light, and refrigerated unless the product label or certificate of analysis gives different handling instructions. Avoid leaving vials in hot rooms, vehicles, direct sunlight, or other temperature swings, because moisture, heat, and light are the main storage conditions people try to control before reconstitution.
Reconstituted: After reconstitution, AOD-9604 should generally be treated as more sensitive: keep it refrigerated, minimize unnecessary handling, avoid shaking, and use clean handling practices each time the vial is accessed. Follow the product label, protocol page, and any pharmacy or lab guidance for beyond-use timing; if the solution changes color, becomes cloudy, develops particles, or the vial integrity is questionable, it should not be used.
Protocol
The full AOD-9604 protocol is included below. The standalone protocol page remains available if you want to open it separately.
Open Standalone Protocol
Scope
Preparation examples, syringe conversion, community-reported patterns and important limitations.
Available strengths: 10 MG
Preparation Examples
These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.
| Setup |
Diluent |
Concentration |
Unit conversion |
| 10 MG vial – 2 mL example |
Add 2 mL supplied acetic-acid water (AA water) |
5 mg/mL |
Each U-100 unit = 50 mcg |
| 10 MG vial – 1 mL example |
Add 1 mL supplied acetic-acid water (AA water) |
10 mg/mL |
Each U-100 unit = 100 mcg |
Syringe Conversion
| Reported amount |
10 MG setup |
10 MG setup |
| 100 mcg |
2 units |
1 units |
| 250 mcg |
5 units |
2.5 units |
| 300 mcg |
6 units |
3 units |
| 500 mcg |
10 units |
5 units |
Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.
Community-Reported Patterns
| Recurring report |
Frequency seen |
Context in reports |
| 250 mcg |
Once daily |
Lower recurring amount |
| 300 mcg |
Once daily |
Most repeated amount reviewed |
| 500 mcg |
Once daily |
Higher community reports |
Observations
- Community discussions most often centered on fat-loss and body-composition goals.
- The amount, frequency, route and cycle length varied substantially between reports.
- Reported outcomes were commonly confounded by diet, training, other products or existing treatment.
Caveats
- AOD-9604 is not an approved weight-loss medication, and online outcomes do not establish benefit or safety. Confirm the product form and the labeled acetic-acid concentration because peptide formulation and aggregation are sensitive to pH and manufacturing conditions.
- Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.